3-Thiazolidinepropanoic acid, 2-[(2-methoxyphenoxy)methyl]-β-oxo-, ethyl ester
CAS : 119637-67-1
Ref. AN-AG000PE9
1g | Arrêté | ||
5g | Arrêté | ||
100mg | Arrêté | ||
250mg | Arrêté | ||
500mg | Arrêté |
Informations sur le produit
Nom :
3-Thiazolidinepropanoic acid, 2-[(2-methoxyphenoxy)methyl]-β-oxo-, ethyl ester
Synonymes :
- [u'2-(2-methoxyphenoxy)methyl-3-ethoxycarbonylacetyl-1,3-thiazolidine', u'BBR 2173', u'BBR-2173', u'ethyl 2-((2-methoxyphenoxy)methyl)-beta-oxothiazolidine-3-propanoate', u'moguisteine', u'Moguisteine', u'119637-67-1', u'BBR-2173', u'Moguisteine [INN]', u'Moguisteinum [INN-Latin]', u'Moguisteina [INN-Spanish]', u'C16H21NO5S', u'Ethyl 2-((2-methoxyphenoxy)methyl)-beta-oxo-3-thiazolidinepropanoate (+-)-', u'R,S(+-)-2-(2-Methoxyphenoxy)-methyl-3-ethoxycarbonylacetyl-1,3-thiazolidine', u'3-Thiazolidinepropanoic acid, 2-((2-methoxyphenoxy)methyl)-beta-oxo-, ethyl ester, (+-)-', u'Moguisteina', u'Moguisteinum', u'Ethyl (+-)-2-((o-methoxyphenoxy)methyl)-beta-oxo-3-thiazolidinepropionate', u'ethyl 3-(2-((2-methoxyphenoxy)methyl)thiazolidin-3-yl)-3-oxopropanoate', u'ethyl 3-[2-[(2-methoxyphenoxy)methyl]-1,3-thiazolidin-3-yl]-3-oxopropanoate', u'Ethyl 3-{2-[(2-methoxyphenoxy)methyl]-1,3-thiazolidin-3-yl}-3-oxopropanoate', u'BBR 2173', u'ACMC-20d7cg', u'AC1Q5JZ1', u'Oprea1_020741', u'MLS006010420', u'SCHEMBL358534', u'AC1L24A2', u'CHEMBL146980', u'CTK8E8094', u'3-Thiazolidinepropanoicacid, 2-[(2-methoxyphenoxy)methyl]-b-oxo-, ethyl ester, (R)- (9CI)', u'HMS3264I22', u'HMS3651H22', u'Pharmakon1600-01502311', u'BCP05219', u'EBD54061', u'HY-B0505', u'KS-00001F7I', u'2-(2-methoxyphenoxy)methyl-3-ethoxycarbonylacetyl-1,3-thiazolidine', u'ethyl 2-((2-methoxyphenoxy)methyl)-beta-oxothiazolidine-3-propanoate', u'MFCD00866839', u'NSC759829', u's3104', u'AKOS015843415', u'AC-4727', u'AN-6527', u'BCP9000958', u'CCG-213816', u'CS-2706', u'KS-5161', u'NSC-759829', u'RTC-070944', u'VA11319', u'121GE004', u'AK343774', u'SMR002529585', u'LS-151527', u'TC-070944', u'FT-0084586', u'FT-0656011', u'SW219622-1', u'BBR2173;BBR 2173;BBR-2173', u'K-1384', u'AB01563359_01', u'AB01563359_02', u'637M671', u'A804330', u'SR-01000944248', u'I06-1738', u'J-004167', u'SR-01000944248-1', u'BRD-A87673115-001-01-7', u'(+/-)-2-(2-Methoxyphenoxy)-methyl-3-ethoxycarbonylacetyl-1,3-thiazolidine', u'(R,S)-2-(2-Methoxyphenoxy)-methyl-3-ethoxycarbonyl-acetyl-1,3 thiazolidine', u'ethyl 3-[2-[(2-methoxyphenoxy)methyl]thiazolidin-3-yl]-3-oxo-propanoate', u'(+/-)-2-[(2-Methoxyphenoxy)methyl]-|A-oxo-3-thiazolidinepropanoic Acid Ethyl Ester', u'3-[2-[(2-methoxyphenoxy)methyl]-3-thiazolidinyl]-3-oxopropanoic acid ethyl ester', u'3-Thiazolidinepropanoic acid, 2-[(2-methoxyphenoxy)methyl]-beta-oxo-, ethyl ester', u'3-Thiazolidinepropanoicacid, 2-[(2-methoxyphenoxy)methyl]-b-oxo-, ethyl ester', u'ethyl 3-[2-[(2-methoxyphenoxy)methyl]-1,3-thiazolidin-3-yl]-3-oxidanylidene-propanoate', u'(+/-)-2-(2-Methoxyphenoxy)-methyl-3-ethoxycarbonylacetyl-1,3-thiazolidine; (R,S)-2-(2-Methoxyphenoxy)-methyl-3-ethoxycarbonyl-acetyl-1,3 thiazolidine', u'ethyl( inverted exclamation markA)-2-((o-methoxyphenoxy)methyl)-b-oxo-3-thiazolidinepropionate', u'R(+)-Moguisteine', u'S(-)-Moguisteine', u'D0TR0Z', u'Moguisteine < Rec INN >', u'UNII-6Y556547YY', u'BBR 2221', u'BBR 2222', u'CID65935', u'C16-H21-N-O5-S', u'6Y556547YY', u'ACN-040065', u'C087933', u'126145-23-1']
- (+/-)-2-(2-Methoxyphenoxy)-methyl-3-ethoxycarbonylacetyl-1,3-thiazolidine
- (R,S)-2-(2-Methoxyphenoxy)-methyl-3-ethoxycarbonyl-acetyl-1,3 thiazolidine
- Bbr 2173
- Ethyl 3-{2-[(2-Methoxyphenoxy)Methyl]-1,3-Thiazolidin-3-Yl}-3-Oxopropanoate
CAS :
Marque:
Indagoo
Stockage à long terme :
Notes :
Propriétés chimiques
Masse moléculaire :
339.4066
Formule :
C16H21NO5S
Degré de pureté :
99%
Couleur/Forme :
Solid
InChI :
InChI=1S/C16H21NO5S/c1-3-21-16(19)10-14(18)17-8-9-23-15(17)11-22-13-7-5-4-6-12(13)20-2/h4-7,15H,3,8-11H2,1-2H3
Code InChI :
WSYVIAQNTFPTBI-UHFFFAOYSA-N
MDL:
Point de fusion :
Point d'ébullition :
Point d'éclair :
Densité :
Concentration :
EINECS :
Merck :
Code SH :